GLP-1 (glucagon-like peptide-1) receptor agonists mimic a hormone in the body that regulates appetite and blood sugar levels
This past spring, multiple officials inside the agency expressed concern that then FDA head Marty Zakary was stacking the hearing with panelists who had direct connections to the peptide industry, according to reporting from the Washington Post published last week
When appeal rights are available, the response may include additional records, updated BMI information, relevant diagnoses, and a provider letter
Exposure to high concentrations of DEHP was shown to produce a wide range of adverse effects in experimental animals, including cancer, liver damage, birth defects, and alterations of the reproductive system, especially for male animals 2,3